iKang Healthcare Group (KANG) Rating Lowered to Hold at BidaskClub

iKang Healthcare Group (NASDAQ:KANG) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday.

Separately, ValuEngine raised iKang Healthcare Group from a “sell” rating to a “hold” rating in a research report on Monday, April 2nd.

Shares of iKang Healthcare Group opened at $19.99 on Wednesday, according to MarketBeat Ratings. The company has a current ratio of 0.76, a quick ratio of 0.74 and a debt-to-equity ratio of 0.03. iKang Healthcare Group has a fifty-two week low of $19.98 and a fifty-two week high of $20.00. The stock has a market cap of $1.39 billion, a PE ratio of 76.92 and a beta of 0.07.

iKang Healthcare Group (NASDAQ:KANG) last issued its earnings results on Thursday, March 22nd. The medical research company reported $0.40 earnings per share for the quarter. iKang Healthcare Group had a return on equity of 4.97% and a net margin of 3.16%. The business had revenue of $206.39 million for the quarter.

Hedge funds and other institutional investors have recently modified their holdings of the company. JPMorgan Chase & Co. acquired a new stake in shares of iKang Healthcare Group during the 1st quarter worth about $147,000. Trexquant Investment LP acquired a new stake in shares of iKang Healthcare Group during the 1st quarter worth about $362,000. Renaissance Technologies LLC acquired a new position in iKang Healthcare Group during the fourth quarter worth approximately $377,000. Quad Capital Management Advisors LLC acquired a new position in iKang Healthcare Group during the first quarter worth approximately $522,111,000. Finally, Two Sigma Advisers LP acquired a new position in iKang Healthcare Group during the fourth quarter worth approximately $414,000. 35.53% of the stock is currently owned by institutional investors and hedge funds.

About iKang Healthcare Group

iKang Healthcare Group, Inc, together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company operates in two segments, Medical Examinations and Other Medical Services, and Dental Services. It offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab tests, electrocardiogram, ultrasound, and X-ray examination items.

Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply